What is ZIVOW's health score?

Zivo Bioscience, Inc. (ZIVOW) has a TradeApes health score of 37 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is ZIVOW's estimated fair value?

Based on our 5-year discounted cash flow model, Zivo Bioscience, Inc.'s estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is ZIVOW undervalued or overvalued?

Our model currently rates ZIVOW as Fair Value. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for ZIVOW... Refresh in a moment for the full analysis.

Zivo Bioscience, Inc. (ZIVOW)

Healthcare Fair Value High weak

Updated: 2026-04-21

TradeApes Score

reduce

Financial Strength

10 Stressed

Operating Trend

60 Healthy

Relative Value

40 Weak

Capital Allocation

30 Weak

Risk

50 Mixed

Key Findings

+ High ROIC — above 20%, excellent return on invested capital

Unlock Full Report →

− Weak interest coverage — earnings barely cover debt service

Unlock Full Report →

2 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.